chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This case was reported by a other health professional via call center representative and described the occurrence of inappropriate age at vaccine administration in a 18-year-old female patient who received HBV (ENGERIX B adult) (batch number K329E, expiry date 24th April 2023) for prophylaxis. On 23rd December 2021, the patient received the 3rd dose of ENGERIX B adult. On 23rd December 2021, unknown after receiving ENGERIX B adult, the patient experienced inappropriate age at vaccine administration and overdose. On an unknown date, the outcome of the inappropriate age at vaccine administration and overdose were unknown. Additional details were reported as follows: As an adolescent patient received an adult dose of ENGERIX B as a third dose of the hepatitis B vaccination series which led to medication error of inappropriate age at vaccine administration and overdose. The reporter consented to follow up.
Fatigue; Sore throat; headache; Running nose; swelling lymph nodes on the neck on the same side where she received the injection; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (Fatigue), OROPHARYNGEAL PAIN (Sore throat), HEADACHE (headache), RHINORRHOEA (Running nose) and LYMPHADENITIS (swelling lymph nodes on the neck on the same side where she received the injection) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 021B21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 30-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Apr-2021, the patient experienced FATIGUE (Fatigue), OROPHARYNGEAL PAIN (Sore throat), HEADACHE (headache), RHINORRHOEA (Running nose) and LYMPHADENITIS (swelling lymph nodes on the neck on the same side where she received the injection). At the time of the report, FATIGUE (Fatigue), OROPHARYNGEAL PAIN (Sore throat), HEADACHE (headache), RHINORRHOEA (Running nose) and LYMPHADENITIS (swelling lymph nodes on the neck on the same side where she received the injection) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
She called student health on 09/04/09 c/o fever(resolved), Hallucinations (resolved), headaches and dizziness.Student was offerred rx maclizine but she declined. Advised to return for worsening symptoms but she has not returned.
Pharmacist discussed dizziness with patient before receiving  2nd dose of Moderna. Received vaccine at 1:23pm. Patient sat after receiving vaccine with pharmacist. Patient felt fine and said she would be ok to sit in post vaccination area. Patient seemed hot and asked to remove her mask. Had patient return to room where vaccine was given because the temperature was cooler. Sat with her in room for a few minutes and she felt better to go back into post vaccination area. About twenty minutes later, patient was still feeling dizzy. Asked patient if she wanted lie down. Patient moved back into immunization room and did not want lie down.  Gave her a cold pack and checked her blood pressure, 140/104. Patient took meclizine 25mg. Patient was talking and said her mouth felt funny.  Offered her benadryl and checked for other symptoms. Patient refused Benadryl. Sat with her awhile longer and patient said she felt ok to leave. Her Mother drove her home. Patient was here about an  hour post vaccination.
Elevated temp (99.5); swelling, heat and pain at injection site; general malaise; muscle and joint pains/aches.
Pt received Moderna vaccine and is only 17. We did not realize at first dose appointment on 3/26/2021 and realized when he came back for his second appointment on 4/23/2021. Per CDC recommendation and with patient and parent approval, second dose was administered and patient is doing well.
This spontaneous report was received from an approximately 77 year-old female patient with penicillin allergy. Her husband contributed as well. The patient's medical history included heart attack 2 years ago. On an unspecified date in 2012, "a year ago", the patient was vaccinated with ZOSTAVAX injection in left arm to prevent shingles. Lot# and administration route were unspecified. Concomitant medication included unspecified heart and blood pressure medication. Since vaccination the patient had had what she described as a pimple that appeared to have burst at the injection site. Sometimes it bleed and sometimes it scab. She had been having it looked at by the doctor who told her to keep it covered with a band aid. No treatment was given. Blood work was done, and no result was reported. The outcome of events was reported as not recovered. The patient sought medical attention via doctor visit. Additional information has been requested.
4" x 2.25" edematous, erythema area around DTaP injection site right deltoid.
RN reported she was vax w/ 1st, 2nd & 3rd dose & failed to seroconvert; she also devel positive core antibody;
This is a spontaneous report from a contactable consumer (medical assistant) received via a Pfizer sales representative. This consumer reported similar events for four patients. This is the third of four reports. An infant patient of an unspecified gender received PREVNAR 13, batch/lot number and expiration date were not reported), via an unspecified route of administration on an unspecified date at a single dose for immunization. The patient's medical history and concomitant medications were not reported. On an unspecified date, the patient experienced swelling and a little hardened area at the injection site. The reporter spoke to the doctor that said the swelling and a little hardened area at the injection site was okay and nothing serious. The outcome of the event was recovered within a few days on their own. The information on the batch/lot number and expiration date has been requested. Sender's Comments: Linked Report(s): US-PFIZER INC-2018482503 Same reporter, same drug, same events; different patient.
Information has been received from a physician concerning a 37 year old male with no reported medical history or allergies who on 08/21/95 and 10/04/95 was vaccinated with first and second doses of varicella virus vaccine live (Lot # 608589/0416B). The physician indicated that the pt's wife had shingles and the pt presented to the MD's office a "couple days later" on 12/10/03 with a varicella-like rash on the trunk of his body. The pt was treated with "Zovrax".  A product complaint was not involved. Additional information has been requested.
pt recv vax & devel intense, burning pain @ the inj site which lasted abut ten minutes;child also screamed for a good 10 minutes;
Vaccine went under temperature excursion; No adverse event; Vaccine went temperature excursion and was administered between 02-MAR-2023 to 28-MAR-2023.; This spontaneous case was reported by a consumer and describes the occurrence of POOR QUALITY PRODUCT ADMINISTERED (Vaccine went temperature excursion and was administered between 02-MAR-2023 to 28-MAR-2023.), PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine went under temperature excursion) and NO ADVERSE EVENT (No adverse event) in an adult patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 066H22A) for COVID-19 prophylaxis.   No Medical History information was reported.    In March 2023, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. In March 2023, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Vaccine went temperature excursion and was administered between 02-MAR-2023 to 28-MAR-2023.). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine went under temperature excursion) and NO ADVERSE EVENT (No adverse event). At the time of the report, POOR QUALITY PRODUCT ADMINISTERED (Vaccine went temperature excursion and was administered between 02-MAR-2023 to 28-MAR-2023.), PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine went under temperature excursion) and NO ADVERSE EVENT (No adverse event) outcome was unknown.     For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for POOR QUALITY PRODUCT ADMINISTERED (Vaccine went temperature excursion and was administered between 02-MAR-2023 to 28-MAR-2023.) and PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine went under temperature excursion).    No concomitant medications were reported.  It was unknown patient receive any other vaccines in the 4 weeks prior to COVID-19 Vaccine.Due to Lost power the in the middle of the day at 12:00 PM, had to place all vaccine into a frozen bag. Booster vaccines were then transported to another clinic.  No treatment information was provided.  This case is of patient 22 out of 26 Patients, as mentioned by the reporter.   This case was linked to US-MODERNATX, INC.-MOD-2023-718370 (Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-718370:Master case
Arm is beat red, had high fever for 24 hours, red arm does not hurt, just red.
Pt came to hospital with shortness of breath and wheezing. sepsis r/t bronchitits 3L of oxygen, antibiotics given and steroids.
This case was reported by a consumer via call center representative and described the occurrence of injection site pain in a adult female patient who received Flu Seasonal QIV Dresden (Influenza vaccine Quadrivalent 2014-2015 season) for prophylaxis. Previously administered products included Flu vaccine with an associated reaction of injection site pain (patient had gotten the flu vaccine every year for the past nine years). On an unknown date, the patient received Influenza vaccine Quadrivalent 2014-2015 season. On an unknown date, less than a year after receiving Influenza vaccine Quadrivalent 2014-2015 season, the patient experienced injection site pain. Rechallenge with Influenza vaccine Quadrivalent 2014-2015 season was positive. On an unknown date, the outcome of the injection site pain was recovered/resolved. It was unknown if the reporter considered the injection site pain to be related to Influenza vaccine Quadrivalent 2014-2015 season. Additional details were provided as follows: The age at the vaccination was not reported. The patient reported that she has gotten the flu vaccine every year for the past nine years and it usually hurts a little at the injection site, but resolved after a couple days. This was third of the 9 cases reported by the same reporter for the same patient.
19 days post vaccine, I began having pain at injection site, left arm, shoulder and neck  at bast of neck where shoulder and neck join (including difficulty turning head).
This spontaneous report as received from a licensed vocational nurse refers to an unspecified number of patients of unknown age and gender. The patient's medical history, concurrent conditions and concomitant medications were not reported. On unspecified dates since 05-OCT-2015, patient were vaccinated with the doses of PROQUAD (Merck) (lot # L027634 with expiration date 21-JAN-2017 and lot # L024125 with expiration date 30-DEC-2016; dose and route of administration were not reported) which were exposed to the temperature outside of the recommended range. No adverse effects have been observed or reported. This is one of several reports received from the same reporter. Additional information has been requested.
Patient received first H1N1 dose on 10/14/2009 and second on 11/20/2009
PAIN IN BACK; PAIN IN CHEST; PAIN IN HEAD; This spontaneous report received from a patient concerned a 39 year old of unspecified sex. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1808982, expiry: UNKNOWN) dose was not reported, administered on 04-JUN-2021 for prophylactic vaccination. No concomitant medications were reported. On 05-JUN-2021, the subject experienced pain in back. On 05-JUN-2021, the subject experienced pain in chest. On 05-JUN-2021, the subject experienced pain in head. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from pain in back, pain in head, and pain in chest. This report was non-serious.
pt recv vax on 17may96 in left arm on 07aug96 pt devel shingles, w/several lesions on the left chest around the shoulder blade and back. pt seen by MD & recovered by 15aug96
Patient was pregnant at time of vaccine administration. The adverse event is that the Moderna COVID-19 vaccine was given to a 17 year old, which at this time is not the recommended age group. No concerns or side-effects noted at this time and will follow-up CDC guidance for second dose and booster.
10/8/98 pt exp numbness, chest pain, weakness, dizziness, & seeing double, dx hyperventilation syndrome.4/8/98, dizziness, given meclizine, 7/1/98 dx w/GERD
Patient with complaints of dizziness immediately after the vaccine and it went away but then when her 15 minutes were almost she started feeling dizzy again. Her vitals were as follows: At 1230 T-96.2 (she said she normally has lower temp of 96-97), O2 sats 98%, HR 83 and BP 94/71 sitting 12.32-BP111/84, HR 84 sitting 12.34 BP 118/79, HR 82 sitting and BP 108/95, HR 83 standing By then she said she started feeling better and came back to the waiting area for another 15 minutes and then left. No other complaints.
Other complications following immunization, not elsewhere classified, subsequent encounter on 2022-01-07.
Pt vaccinated x3 (Pfizer: 3/22/21, 4/12/21, 10/28/21) Pt tested positive for COVID 6/17/22 and admitted to hospital
Starting next day after booster, she noticed that her fingers of hands and foot are tingling/she feels tingling and numbness every day; Going numb/she feels tingling and numbness every day; has been having vertigo that started next day after taking booster dose.; This spontaneous case was reported by a patient and describes the occurrence of PARAESTHESIA (Starting next day after booster, she noticed that her fingers of hands and foot are tingling/she feels tingling and numbness every day), HYPOAESTHESIA (Going numb/she feels tingling and numbness every day) and VERTIGO (has been having vertigo that started next day after taking booster dose.) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 017F21A) for COVID-19 vaccination.     Concomitant products included LEVOTHYROXINE SODIUM (SYNTHROID) for an unknown indication.    On 01-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Nov-2021, the patient experienced PARAESTHESIA (Starting next day after booster, she noticed that her fingers of hands and foot are tingling/she feels tingling and numbness every day), HYPOAESTHESIA (Going numb/she feels tingling and numbness every day) and VERTIGO (has been having vertigo that started next day after taking booster dose.). At the time of the report, PARAESTHESIA (Starting next day after booster, she noticed that her fingers of hands and foot are tingling/she feels tingling and numbness every day), HYPOAESTHESIA (Going numb/she feels tingling and numbness every day) and VERTIGO (has been having vertigo that started next day after taking booster dose.) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Patient had reported his treatment with Hot Bath.  Concomitant product use was not provided by the reporter. Treatment information was not provided by the reporter.    This case was linked to MOD-2021-386892, MOD-2021-386875 (Patient Link).
This spontaneous report as received from a medical assistant refers to a patient of unknown age and gender. No information regarding the patient's pertinent medical history, drug reactions or allergies and concomitant medications was provided. On 05-FEB-2019, the patient was vaccinated with a dose of improperly stored VARIVAX lot # N034551, expiration date: 05-DEC-2019 for prophylaxis (dose and route of administration were not reported). The vaccine was reconstituted with properly stored sterile diluent. Administered dose of vaccine experienced the temperature excursion of 21.7 degrees Fahrenheit for 3 hours 45 minutes and previous temperature excursion of 12.9 degrees Fahrenheit for 30 minutes. Data logger was involved. No adverse effects were reported. This is one of several reports received from the same reporter. Sender's Comments: US-009507513-1902USA003115: US-009507513-1902USA004130: US-009507513-1902USA004131.
Sore arm starting ~2 hr after vaccine, lasting ~24-36 hours Headache, Fever (>102-103F), & Chills starting ~12 hr after vaccination and lasting ~12 hr
PATIENT REPORTED GETTING "SHINGLES RASH" ON HIS TRUNK ABOUT 2-3 DAYS AFTER RECEIVING THE VACCINE- PATIENT RECEIVED THE SHINGRIX.  I INFORMED HIM TO CONTACT HIS PCP FOR EVALUATION OF THE RASH AND TREATMENT.
Dizziness, light headed, rapid breathing, numbness started in hands and feel the numbness moving up my to my forearms, hands clamped and fingers locked in  claw like position - called 911 since this happened while I was driving home
fatigue, injection sign pain Narrative:  Pt called COVID-19 Adverse event hotline to report symptoms of sore arm, headache, and fatigue s/p first dose of the Pfizer vaccine on 2/24/21. Pt reports symptoms are improving since yesterday when he received the vaccine.
tender to touch on left head/scalp, left ear and neck; Hives; skin rash; Throbbing headache; This spontaneous case was reported by a consumer and describes the occurrence of TENDERNESS (tender to touch on left head/scalp, left ear and neck), URTICARIA (Hives), RASH (skin rash) and HEADACHE (Throbbing headache) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced TENDERNESS (tender to touch on left head/scalp, left ear and neck), URTICARIA (Hives), RASH (skin rash) and HEADACHE (Throbbing headache). At the time of the report, TENDERNESS (tender to touch on left head/scalp, left ear and neck), URTICARIA (Hives), RASH (skin rash) and HEADACHE (Throbbing headache) had not resolved.            No concomitant medications reported by reporter No treatment medications provided by the reporter.   Patient stated that two weeks post booster, patient had throbbing headache, skin rash/ hive and tender to touch on left head/scalp, left ear and neck. Its day 4 of these symptoms.
High blood pressure - it's over 200. I called the doctor and went in- they told me to go to ER at hospital in area. ER gave me a Tylenol and three pills and didn't tell me what they were. He told me at the time that he believed it was caused by the Prolia shot. So they sent me home. It went down that day and I slept but it didn't go back down good, just below 200. But the rest of the week is what going up again. I called the doctor and went in and they told me to go to ER again. The second time, they didn't give me anything and sent me home. Now it's gradually going down. It was 179 over something not too long ago. It went up to 231 in the hospital when they checked it. I had a headache but I thought it was allergies but I'm beginning to think it was from the blood pressure. I have taken medicine for blood pressure but it has stayed medicine but now after the vaccine and the Prolia shot (I had had cancer) it isn't. My arthritis has been feeling worse and now I found out that I have carpal tunnel and I'm going to a doctor for that one. They are a new doctor for that. Yesterday, when I took my blood pressure it was down and I'm not jerking as bad.
Received HPV and H1N1 vaccine. RN accompanied client to bill pay and told to wait 15 min before leaving. Client fell while waiting at bill pay and hit back of head on floor. Unresponsive approx 30 sec BP 118/78, P64, R16. Waited at  HD about 40 min - ER with friend. No Rx at ER.
I started taking benadryl and ibuprofen starting the day after the shot. I had an adverse avent to the first shot and was trying to keep it from happening again. I stopped taking them on Monday May 10. The next day my arm was swollen and a rash developed about 4" x 6: near the injection site and the arm became painful. I'm currently taking benadryl however the rash is spreading. It's on both arms, my torso and started down my legs.
It's been quite some time since the shot and I am having trouble lifting and using my left arm.  I have also had pain radiating from the shoulder, muscle cramps in my arm and stomach, and an increase in trouble seeing.  I wear glasses and do not have eye diseases other than cataract.  Severe fatigue.  Stomach fluttering.  Swollen lymph glands under right arm and above right breast
Hepatitis A vaccine given that was expired in 2010. Patient has had no adverse reaction to date.
Severe fatigue, muscle aches, brain fog, nausea, sore throat, swollen lymph nodes, fever
Information has been received from a pharmacist concerning a female with fibromyalgia and hypersensitive to pain who on 21-JAN-2011, report as "3 days ago", was vaccinated with ZOSTAVAX (Merck) (lot # not reported). Concomitant medication, drug reactions and allergies were all unspecified. In the night after vaccination, also reported as "3 days ago" on 21-JAN-2011, the patient experienced injection site pain, the "electric jolts" in her legs and "large toe". The pharmacist also reported that the injection might have given intramuscularly. The patient sought medical attention via calling pharmacy. The status of the patient was unknown. Additional information has been requested.
Patient did NOT qualify for an "additional" dose. However, mistakenly, patient did receive a THIRD shot of Moderna.  Patient did not indicate any complications.
Pt recv vax on 12/9/98; 1 hr post vax pt exp vomiting, passed out, hit head
fevers, nausea, local reaction on day 1.   However day 14 patient now has large patch of erythema about 12cm across centered around medial elbow.  Erythema from local reaction has traveled down patient's arm.
Reported amenorrhea since booster.  She also had menstrual changes after her last booster.  Her periods did return to normal within a short time after her first booster